in India

dr reddy’s laboratories shares: Dr Reddy’s Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancer

100 Views

Dr Reddy’s Laboratories shares rise 2.2% on Friday after the firm announced the launch of toripalimab, an immune oncology drug to treat adults with a rare and aggressive form of head and neck cancer that originates in the nasopharynx, the upper part of the throat.

Toripalimab, a new biological…

Read More

What do you think?

0 Points
Upvote Downvote

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Zen Technologies Expects 10% Revenue From T90 Gunnery Simulators Over 3 Years: Chairman Ashok Atluri

How To Trade PNB, Aegis Logistics, Container Corp, Engineers India, BHEL